期刊文献+

白介素2受体及其与肿瘤免疫逃逸 被引量:5

原文传递
导出
摘要 白介素 2 (IL 2 ) /白介素 2受体 (IL 2R )在细胞因子网络调节中起关键作用。至少有三种IL 2R亚基 :α、β和γ链 ,β链和γ链是形成功能性IL 2R的必需亚基。IL 2与IL 2R结合激活多种信号转导途径 ,其中Jak STAT最为重要。IL 2R及其下游信号分子缺陷可能是肿瘤免疫逃逸的重要原因 ,纠正这种缺陷可用于肿瘤治疗的尝试。
出处 《上海免疫学杂志》 CSCD 北大核心 2002年第2期132-134,共3页 Shanghai Journal of Immunology
  • 相关文献

参考文献1

二级参考文献20

  • 1Xuetao Cao,Guoyou Chen,Long He,Weiping Zhang,Yizhi Yu,TianXing Ye.Chemoattractive effect on the effector cells of the supernatants from melanoma cells transfected with the interleukin-2 (IL-2), IL-4 or IL-6 gene[J]. Journal of Cancer Research and Clinical Oncology . 1998 (2)
  • 2Paul B. Chapman,Jonathan E. Kolitz,Thomas B. Hakes,Janice L. Gabrilove,Karl Welte,V. J. Merluzzi,Adelheid Engert,Edward C. Bradley,Michael Konrad,Roland Mertelsmann.A phase I trial of intraperitoneal recombinant interleukin 2 in patients with ovarian carcinoma[J]. Investigational New Drugs . 1988 (3)
  • 3Chapman PB,Kolitz JE,Hakes TB,et al.A phase Ⅰ trial of intraperitoneal recombinant interleukin-2 in patients with ovarian carcinoma. Investigational New Drugs . 1988
  • 4Stewart JA,Belinson JL,Moore AL,et al.Phase Ⅰ trial of intraperitoneal recombinant interleukin-2/lymphokine-activated killer cells in patients with ovarian cancer. Cancer Research . 1990
  • 5Aoki Y,Takakuwa K,Kodama S,et al.Use of adotive transfer of tumor infiltrating lymphocytes alone or in combination with cisplatin-containing chemotherapy in patients with epithelial ovarian cancer. Cancer Research . 1991
  • 6Howard OMZ,Kirken RA,Garcia GG,et al.Structural domains of interleukin-2 receptor βcritical for signal transduction: kinase association and nuclear complex-formation. European Journal of Immunology . 1996
  • 7Erard F,Corthesy P,Nabholz M,et al.Interleukin-2 is both necessary and sufficient for the growth and differentiation of lectinstimulated cytolytic T lymphocytes precusors. J Immunol . 1985
  • 8Grimm EA,Mazumder A,Zhang HZ,et al.Lymphokine-activated killer cell phenomenon lysis of natural killer-resistant fresh solid tumor cells by interleukin-2 activated autologous human peripheral blood lymphocytes. The Journal of Experimental Medicine . 1982
  • 9Mulders P,Tso CL,Pang S,et al.Adenovirus-mediated interleukin-2 production by tumors induces growth of cytotoxic tumor infiltrating lymphocytes against human renal cell carcinoma. J Immunol . 1998
  • 10Cao X,Chen G,He L,et al.Chemoattractive effect on the effector cells of the supernatants from melanoma cells transfected with the interleukin 2 (IL-2), IL-4, or IL-6 gene. Journal of Cancer Research and Clinical Oncology . 1998

共引文献2

同被引文献62

  • 1侯庆.心理应激、脑海马损伤与抑郁症[J].中国临床康复,2005,9(32):174-176. 被引量:19
  • 2修方明,曹雪涛,杨志峰,于益芝,徐志工,马施华.白介素12增强白介素4基因转染的肿瘤细胞诱导CTL的研究[J].中国免疫学杂志,1996,12(3):159-162. 被引量:2
  • 3曾丛梅,蔡树涛,周凤兰,张锦珠,王平.ConA激活小鼠胸腺T淋巴细胞增殖过程中c-myc与核骨架蛋白的结合[J].中国科学(C辑),1996,26(4):326-330. 被引量:2
  • 4Bussel JB. Novel approaches to refractory immune thrombocytopenicpurpura[J] .Blood Rev, 2002,16(11) :31 - 36.
  • 5Araki K, Harada K, Nakamoto K, et al. Clinical significance of serum soluble IL-2R levels in patients with adult T cell leukaemia(ATL) and HTLV- 1 carriers[J]. Clin Exp Immunol,2000,119(2) :259 - 263.
  • 6Wang JC, Wang A. Plasma soluble interleukin-2 receptor in patients with primary myelofibrosis[J]. Br J Haematol, 1994, 86(4):380 -382.
  • 7Webber NP, Mascarenhas JO, Crow NK, et al. Functional properties of lymphocytes in Idiopathic Thrombocytopenic Purpura[J]. Hum Imrmmol, 2001,62(12): 1345 - 1355.
  • 8叶维新 陈杞 孝延龄.实验核医学技术[M].长春:吉林科学技术出版社,1991.40-42.
  • 9Fehniger T A, Cooper M A, Caligiuri M A. Interleukin-2 and interleukin-15: immunotherapy for cancer[J]. Cytokine Growth Factor Rev, 2002,13:169-183.
  • 10de Paoli P. Immunological effects of interleukin-2 therapy in human immunodeficiency virus-positive subjects[J]. Clin Diag Lab Immunol, 2001,8(4):671-677.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部